The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss

Background. The modified Bushen Antai recipe (BSAT) is a centuries-old traditional Chinese medicine that we use in our center as a therapy against pregnancy loss. Our study aimed to explore the potential benefit and mechanism of BSAT in pregnant rats with mifepristone-induced pregnancy loss. Materia...

Full description

Bibliographic Details
Main Authors: Li Sun, Zhengwei Yuan, Lingyan Jian, Qinghua Jiang, Siwen Zhang, Jichun Tan
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2019/8312020
id doaj-883d8f9187f14a44a5b796a7d43687d4
record_format Article
spelling doaj-883d8f9187f14a44a5b796a7d43687d42020-11-24T22:10:39ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882019-01-01201910.1155/2019/83120208312020The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy LossLi Sun0Zhengwei Yuan1Lingyan Jian2Qinghua Jiang3Siwen Zhang4Jichun Tan5Reproductive Medicine Center, Obstetrics and Gynecology Department, Shengjing Hospital Affiliated to China Medical University, Shenyang 110022, ChinaKey Laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital Affiliated to China Medical University, Shenyang 110022, ChinaDepartment of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110022, ChinaDepartment of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110022, ChinaReproductive Medicine Center, Obstetrics and Gynecology Department, Shengjing Hospital Affiliated to China Medical University, Shenyang 110022, ChinaReproductive Medicine Center, Obstetrics and Gynecology Department, Shengjing Hospital Affiliated to China Medical University, Shenyang 110022, ChinaBackground. The modified Bushen Antai recipe (BSAT) is a centuries-old traditional Chinese medicine that we use in our center as a therapy against pregnancy loss. Our study aimed to explore the potential benefit and mechanism of BSAT in pregnant rats with mifepristone-induced pregnancy loss. Materials and Methods. The signature compounds of the eight BSAT ingredients were analyzed by high-performance liquid chromatography (HPLC). The BSAT group (n = 8) was treated daily with 6.3 ml/kg BSAT from gestation day (D) 0.5 to 10.5 and once with 1.25 mg/kg mifepristone on D 10.5. Normal saline replaced BSAT in the model group (n = 8), and both BSAT and mifepristone in the control group (n = 8). Morphological and histological analyses were performed on D 13.5. Results. BSAT contains eight medicinal ingredients including Cuscuta chinensis and Dipsacus asperoides. The HPLC analysis detected the signature compounds of seven medicinal ingredients in the extract. Embryo resorption rate in the BSAT group was significantly lower than that in the model group, although the number of surviving embryos was similar between the two groups. Hematoxylin and eosin (HE) staining suggested that the maximum cross-sectional area of the placenta and the area ratio of the placental labyrinth in the BSAT group were higher than those in the model group. Immunohistochemical (IHC) staining indicated that the expression of ki67, estrogen receptor alpha (ERα), and progesterone receptor (PR) in the placental labyrinth of the BSAT group was higher than that of the model group. Furthermore, the protein levels of ERα, PR, phospho-Akt/Akt, and phospho-Erk1/2/Erk1/2 in the BSAT group were higher than those in the control group. The mRNA levels of ERα and PR in the BSAT group were higher than those in the control group. Conclusions. BSAT may induce estrogen and progesterone receptors by phosphorylation via the classic Akt and Erk1/2 signaling pathways in the maternal-fetal interface of pregnant rats, thereby reducing the pregnancy loss rate and improving the live birth rate.http://dx.doi.org/10.1155/2019/8312020
collection DOAJ
language English
format Article
sources DOAJ
author Li Sun
Zhengwei Yuan
Lingyan Jian
Qinghua Jiang
Siwen Zhang
Jichun Tan
spellingShingle Li Sun
Zhengwei Yuan
Lingyan Jian
Qinghua Jiang
Siwen Zhang
Jichun Tan
The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss
Evidence-Based Complementary and Alternative Medicine
author_facet Li Sun
Zhengwei Yuan
Lingyan Jian
Qinghua Jiang
Siwen Zhang
Jichun Tan
author_sort Li Sun
title The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss
title_short The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss
title_full The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss
title_fullStr The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss
title_full_unstemmed The Modified Bushen Antai Recipe Upregulates Estrogen and Progesterone Receptors at the Maternal-Fetal Interface in Pregnant Rats with Mifepristone-Induced Pregnancy Loss
title_sort modified bushen antai recipe upregulates estrogen and progesterone receptors at the maternal-fetal interface in pregnant rats with mifepristone-induced pregnancy loss
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2019-01-01
description Background. The modified Bushen Antai recipe (BSAT) is a centuries-old traditional Chinese medicine that we use in our center as a therapy against pregnancy loss. Our study aimed to explore the potential benefit and mechanism of BSAT in pregnant rats with mifepristone-induced pregnancy loss. Materials and Methods. The signature compounds of the eight BSAT ingredients were analyzed by high-performance liquid chromatography (HPLC). The BSAT group (n = 8) was treated daily with 6.3 ml/kg BSAT from gestation day (D) 0.5 to 10.5 and once with 1.25 mg/kg mifepristone on D 10.5. Normal saline replaced BSAT in the model group (n = 8), and both BSAT and mifepristone in the control group (n = 8). Morphological and histological analyses were performed on D 13.5. Results. BSAT contains eight medicinal ingredients including Cuscuta chinensis and Dipsacus asperoides. The HPLC analysis detected the signature compounds of seven medicinal ingredients in the extract. Embryo resorption rate in the BSAT group was significantly lower than that in the model group, although the number of surviving embryos was similar between the two groups. Hematoxylin and eosin (HE) staining suggested that the maximum cross-sectional area of the placenta and the area ratio of the placental labyrinth in the BSAT group were higher than those in the model group. Immunohistochemical (IHC) staining indicated that the expression of ki67, estrogen receptor alpha (ERα), and progesterone receptor (PR) in the placental labyrinth of the BSAT group was higher than that of the model group. Furthermore, the protein levels of ERα, PR, phospho-Akt/Akt, and phospho-Erk1/2/Erk1/2 in the BSAT group were higher than those in the control group. The mRNA levels of ERα and PR in the BSAT group were higher than those in the control group. Conclusions. BSAT may induce estrogen and progesterone receptors by phosphorylation via the classic Akt and Erk1/2 signaling pathways in the maternal-fetal interface of pregnant rats, thereby reducing the pregnancy loss rate and improving the live birth rate.
url http://dx.doi.org/10.1155/2019/8312020
work_keys_str_mv AT lisun themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT zhengweiyuan themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT lingyanjian themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT qinghuajiang themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT siwenzhang themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT jichuntan themodifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT lisun modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT zhengweiyuan modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT lingyanjian modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT qinghuajiang modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT siwenzhang modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
AT jichuntan modifiedbushenantairecipeupregulatesestrogenandprogesteronereceptorsatthematernalfetalinterfaceinpregnantratswithmifepristoneinducedpregnancyloss
_version_ 1725807239776698368